The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety analysis by treatment periods from EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization with durvalumab with/without bevacizumab in participants with embolization-eligible unresectable hepatocellular carcinoma.
 
Masatoshi Kudo
Honoraria - AstraZeneca; Bayer; Chugai/Roche; Eisai; Lilly Japan; Takeda
Consulting or Advisory Role - AstraZeneca; Chugai/Roche; Eisai; Roche
Research Funding - Abbvie (Inst); Chugai/Roche (Inst); Eisai (Inst); GE Healthcare (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst)
 
Stephen Lam Chan
Honoraria - AstraZeneca; Eisai; MSD; Roche
Consulting or Advisory Role - AstraZeneca; BMS; Eisai; MSD Oncology; Roche
Research Funding - Eisai; MSD
Travel, Accommodations, Expenses - Ipsen; Roche
 
Bruno Sangro
Consulting or Advisory Role - AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb; Eisai; Incyte; Roche/Genentech; Sanofi Pasteur; Sirtex Medical
Speakers' Bureau - AstraZeneca; Eisai; Incyte; Roche
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Eisai; Roche; Sirtex Medical
 
Joseph P. Erinjeri
Consulting or Advisory Role - AstraZeneca
 
Shukui Qin
No Relationships to Disclose
 
Zhenggang Ren
Consulting or Advisory Role - MSD; Roche
 
Yasuaki Arai
Speakers' Bureau - AstraZeneca; Boston Scientific; Canon Medical System; Cosmotec; Guerbet; Merit Medical Systems; Merit Medical Systems; Sumitomo Chemical; TERUMO
Patents, Royalties, Other Intellectual Property - Sumitomo Chemical
 
Valeriy Vladimirovich Breder
Honoraria - AstraZeneca; Eisai; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; Roche
Travel, Accommodations, Expenses - Bayer; Roche
 
Shi-Ming Lin
No Relationships to Disclose
 
Jean-Marie Peron
No Relationships to Disclose
 
Tien Quang Nguyen
No Relationships to Disclose
 
Lunan Yan
No Relationships to Disclose
 
Chang-Fang Chiu
No Relationships to Disclose
 
Florinda A. Santos
No Relationships to Disclose
 
Anil Veluvolu
No Relationships to Disclose
 
Satheesh Chiradoni Thungappa
No Relationships to Disclose
 
Claire Morgan
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Kerry Parsons
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Ioannis Xynos
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Riccardo Lencioni
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca (Inst)